IRIS Accounts Production v23.4.0.336 09529939 director 1.7.22 30.6.23 30.6.23 0 0 true false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh095299392022-06-30095299392023-06-30095299392022-07-012023-06-30095299392021-06-30095299392021-07-012022-06-30095299392022-06-3009529939ns15:EnglandWales2022-07-012023-06-3009529939ns14:PoundSterling2022-07-012023-06-3009529939ns10:Director12022-07-012023-06-3009529939ns10:PrivateLimitedCompanyLtd2022-07-012023-06-3009529939ns10:SmallEntities2022-07-012023-06-3009529939ns10:AuditExempt-NoAccountantsReport2022-07-012023-06-3009529939ns10:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3009529939ns10:SmallCompaniesRegimeForAccounts2022-07-012023-06-3009529939ns10:FullAccounts2022-07-012023-06-3009529939ns10:OrdinaryShareClass12022-07-012023-06-3009529939ns10:RegisteredOffice2022-07-012023-06-3009529939ns5:CurrentFinancialInstruments2023-06-3009529939ns5:CurrentFinancialInstruments2022-06-3009529939ns5:Non-currentFinancialInstruments2023-06-3009529939ns5:Non-currentFinancialInstruments2022-06-3009529939ns5:ShareCapital2023-06-3009529939ns5:ShareCapital2022-06-3009529939ns5:RetainedEarningsAccumulatedLosses2023-06-3009529939ns5:RetainedEarningsAccumulatedLosses2022-06-3009529939ns5:CostValuation2022-06-3009529939ns5:Subsidiary12022-07-012023-06-3009529939ns5:Subsidiary112022-07-012023-06-3009529939ns5:Subsidiary12023-06-3009529939ns5:Subsidiary12022-06-3009529939ns5:Subsidiary12021-07-012022-06-3009529939ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-06-3009529939ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-06-3009529939ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-06-3009529939ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2022-06-3009529939ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-06-3009529939ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2022-06-3009529939ns5:Secured2023-06-3009529939ns5:Secured2022-06-3009529939ns10:OrdinaryShareClass12023-06-3009529939ns5:RetainedEarningsAccumulatedLosses2022-06-3009529939ns5:RetainedEarningsAccumulatedLosses2022-07-012023-06-30
REGISTERED NUMBER: 09529939 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2023

FOR

DK HEALTHCARE LIMITED

DK HEALTHCARE LIMITED (REGISTERED NUMBER: 09529939)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


DK HEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2023







DIRECTOR: J D Patel



REGISTERED OFFICE: 2 Cedargrove
Hagley
Stourbridge
West Midlands
DY9 0DR



REGISTERED NUMBER: 09529939 (England and Wales)



ACCOUNTANTS: Ashcrofts Accountants Limited
2 Cedargrove
Hagley
Stourbridge
West Midlands
DY9 0DR



BANKERS: Santander UK plc
Bootle
Merseyside
L30 4GB

DK HEALTHCARE LIMITED (REGISTERED NUMBER: 09529939)

BALANCE SHEET
30 JUNE 2023

2023 2022
Notes £    £   
FIXED ASSETS
Investments 4 1,120,744 1,120,744

CURRENT ASSETS
Cash at bank 851 1,901

CREDITORS
Amounts falling due within one year 5 (404,358 ) (438,490 )
NET CURRENT LIABILITIES (403,507 ) (436,589 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

717,237

684,155

CREDITORS
Amounts falling due after more than one
year

6

(150,809

)

(239,568

)
NET ASSETS 566,428 444,587

CAPITAL AND RESERVES
Called up share capital 9 40 40
Retained earnings 10 566,388 444,547
SHAREHOLDERS' FUNDS 566,428 444,587

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 12 March 2024 and were signed by:



J D Patel - Director


DK HEALTHCARE LIMITED (REGISTERED NUMBER: 09529939)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023


1. STATUTORY INFORMATION

DK Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

4. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 July 2022
and 30 June 2023 1,120,744
NET BOOK VALUE
At 30 June 2023 1,120,744
At 30 June 2022 1,120,744

DK HEALTHCARE LIMITED (REGISTERED NUMBER: 09529939)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2023


4. FIXED ASSET INVESTMENTS - continued

The company's investments at the Balance Sheet date in the share capital of companies include the following:

JJP Healthcare Limited
Registered office:
Nature of business: Retail pharmacy
%
Class of shares: holding
Ordinary shares 100.00
2023 2022
£    £   
Aggregate capital and reserves 931,817 933,953
Profit for the year 182,664 246,041

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts (see note 7) 87,440 84,843
Amounts owed to group undertakings 294,751 330,751
Corporation tax 3,528 4,377
Directors' loan accounts 17,906 17,906
Accruals and deferred income 733 613
404,358 438,490

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans (see note 7) 150,809 239,568

7. LOANS

An analysis of the maturity of loans is given below:

2023 2022
£    £   
Amounts falling due within one year or on demand:
Bank loans 87,440 84,843

Amounts falling due between one and two years:
Bank loans - 1-2 years 87,438 86,042

Amounts falling due between two and five years:
Bank loans - 2-5 years 63,371 153,526

DK HEALTHCARE LIMITED (REGISTERED NUMBER: 09529939)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2023


8. SECURED DEBTS

The following secured debts are included within creditors:

2023 2022
£    £   
Bank loans 238,249 324,411

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
40 Ordinary £1 40 40

10. RESERVES
Retained
earnings
£   

At 1 July 2022 444,547
Profit for the year 199,841
Dividends (78,000 )
At 30 June 2023 566,388

11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

At 30 June 2023 there was a loan from Mr J D Patel of £17,906 (2022: £17,906). This unsecured loan is interest free and repayable on demand.

12. RELATED PARTY DISCLOSURES

At 30 June 2023 there was a loan due to JJP Healthcare Limited of £294,751 (2022: £330,751), a company in which Mr J D Patel is a director. The company is the parent undertaking of JJP Healthcare Limited. This unsecured loan is interest free and repayable on demand.